San Diego, CA, United States of America

Bryan Knox

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Currax Pharmaceuticals LLC, Pernix Sleep, Inc.. Active years: 2017-2021.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Bryan Knox

Introduction

Bryan Knox is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sleep aids. With a total of four patents to his name, Knox has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

One of Knox's latest patents is focused on low-dose doxepin formulations and methods of making and using the same. This invention relates to low-dose oral doxepin pharmaceutical formulations designed to promote sleep. The formulations aim to provide an effective solution for individuals seeking assistance with sleep disorders.

Career Highlights

Throughout his career, Bryan Knox has worked with several prominent companies in the pharmaceutical industry. Notable among these are Pernix Sleep, Inc. and Currax Pharmaceuticals LLC. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of effective sleep medications.

Collaborations

Knox has collaborated with various professionals in his field, including Luigi Schioppi and Brian Talmadge Dorsey. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Bryan Knox's contributions to the pharmaceutical industry, particularly in sleep aid formulations, highlight his role as an influential inventor. His patents reflect a dedication to improving the quality of life for individuals struggling with sleep issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…